Please enable JavaScript to continue using this application.

Compare $SPRO vs $TXTM | Chartloom

Compare

$SPRO vs $TXTM

Spero Therapeutics Inc · Protext Mobility Inc

SPRO

Spero Therapeutics Inc

TXTM

Protext Mobility Inc

Compare $SPRO vs $TXTM

Comparing Spero Therapeutics Inc and Protext Mobility Inc

SPROSpero Therapeutics Inc

TXTMProtext Mobility Inc

SPROSpero Therapeutics Inc

Market cap

$69M

P/E (TTM)

9.42x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-3.3%

YTD performance

-48.9%

52W performance

-47.4%

FCF yield

28.2%

TXTMProtext Mobility Inc

Market cap

$65M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

100.0%

52W performance

184.6%

FCF yield

-1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SPRO

TXTM

Detailed metrics comparison

SPRO

Spero Therapeutics Inc

TXTM

Protext Mobility Inc

Market Cap

SPRO$69M

TXTM$65M

Enterprise Value

SPRO$19M

TXTM$66M

Price

SPRO$1.20

TXTM$0.01

P/E Ratio

SPRO9.42x

TXTMN/A

P/S Ratio

SPRO1.48x

TXTM81,318.79x

EV/Sales

SPRO0.40x

TXTM83,093.29x

EV/EBITDA

SPRO0.78x

TXTM0.00x

P/B Ratio

SPRO1.57x

TXTMN/A

P/FCF Ratio

SPRO3.55x

TXTMN/A

EV/FCF

SPRO0.96x

TXTM-94.20x

PEG Ratio

SPRON/A

TXTMN/A

Forward P/E (NTM)

SPRON/A

TXTMN/A

Forward P/S (NTM)

SPRON/A

TXTMN/A

Revenue (TTM)

SPRO$47M

TXTM$800

Revenue Growth (YoY)

SPRO-3.3%

TXTMN/A

Forward Rev Growth

SPRO300.0%

TXTM0.0%

Gross Margin (TTM)

SPRO0.0%

TXTM87.5%

Operating Margin (TTM)

SPRO22.1%

TXTM0.0%

EBITDA Margin (TTM)

SPRO51.2%

TXTM-128712.5%

Net Margin (TTM)

SPRO15.7%

TXTM-276562.5%

FCF Margin (TTM)

SPRO41.7%

TXTM-88212.5%

Net Income (TTM)

SPRO$7M

TXTM$-2M

FCF (TTM)

SPRO$20M

TXTM$-706K

EPS (TTM)

SPRO$0.13

TXTM-$0.01

ROE (TTM)

SPRO16.2%

TXTM-940097.1%

ROA (TTM)

SPRO12.6%

TXTM-522856.0%

ROIC (TTM)

SPRO16.2%

TXTM0.0%

Cash

SPRO$51M

TXTM$700

Debt

SPRO$0

TXTM$1M

Net Cash/Debt

SPRO$51M

TXTM$-1M

Current Ratio (TTM)

SPRO6.12x

TXTM0.00x

Quick Ratio (TTM)

SPRO6.03x

TXTM0.00x

Debt/Equity (TTM)

SPRO0.00x

TXTM0.00x

Debt/Assets (TTM)

SPRO0.0%

TXTM0.0%

Interest Coverage (TTM)

SPRON/A

TXTMN/A

Net Debt/EBITDA (TTM)

SPRO0.00x

TXTM0.00x

Beta

SPRO1.54

TXTM-3.17

52W Performance

SPRO-47.4%

TXTM184.6%

YTD Performance

SPRO-48.9%

TXTM100.0%

% from 52W High

SPRO-61.0%

TXTM-26.0%

% from 52W Low

SPRO11.1%

TXTM393.3%

Asset Turnover (TTM)

SPRO1.00x

TXTM0.04x

FCF Yield (TTM)

SPRO28.2%

TXTM-1.1%

Earnings Yield (TTM)

SPRO10.6%

TXTM-3.4%

Dividend Yield (TTM)

SPRON/A

TXTMN/A

Rule of 40

SPRO38.4

TXTM-88,212.5

EV/GP/RG

SPRON/A

TXTMN/A

Ticker research

View SPRO research View TXTM research

Metric	SPRO Spero Therapeutics Inc	TXTM Protext Mobility Inc
Market & Valuation
Market Cap	$69M	$65M
Enterprise Value	$19M	$66M
Price	$1.20	$0.01
P/E Ratio	9.42x	N/A
P/S Ratio	1.48x	81,318.79x
EV/Sales	0.40x	83,093.29x
EV/EBITDA	0.78x	0.00x
P/B Ratio	1.57x	N/A
P/FCF Ratio	3.55x	N/A
EV/FCF	0.96x	-94.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$47M	$800
Revenue Growth (YoY)	-3.3%	N/A
Forward Rev Growth	300.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	87.5%
Operating Margin (TTM)	22.1%	0.0%
EBITDA Margin (TTM)	51.2%	-128712.5%
Net Margin (TTM)	15.7%	-276562.5%
FCF Margin (TTM)	41.7%	-88212.5%
Net Income (TTM)	$7M	$-2M
FCF (TTM)	$20M	$-706K
EPS (TTM)	$0.13	-$0.01
ROE (TTM)	16.2%	-940097.1%
ROA (TTM)	12.6%	-522856.0%
ROIC (TTM)	16.2%	0.0%
Financial Health
Cash	$51M	$700
Debt	$0	$1M
Net Cash/Debt	$51M	$-1M
Current Ratio (TTM)	6.12x	0.00x
Quick Ratio (TTM)	6.03x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	-3.17
52W Performance	-47.4%	184.6%
YTD Performance	-48.9%	100.0%
% from 52W High	-61.0%	-26.0%
% from 52W Low	11.1%	393.3%
Efficiency & Yields
Asset Turnover (TTM)	1.00x	0.04x
FCF Yield (TTM)	28.2%	-1.1%
Earnings Yield (TTM)	10.6%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	38.4	-88,212.5
EV/GP/RG	N/A	N/A
Ticker research	View SPRO research	View TXTM research

Valuation

P/E Ratio

SPRO

9.42x

P/S Ratio

SPRO

1.48x

TXTM

81,318.79x

EV/FCF

TXTM

-94.20x

SPRO

0.96x

Growth & revenue

Revenue Growth TTM

SPRO

-3.3%

Forward Revenue Growth

SPRO

300.0%

TXTM

0.0%

Profitability & performance

Gross Margin

TXTM

87.5%

SPRO

0.0%

ROE

SPRO

16.2%

TXTM

-940097.1%

FCF Yield %

SPRO

28.2%

TXTM

-1.1%

52-Week Performance

TXTM

184.6%

SPRO

-47.4%

Detailed metrics comparison

SPRO

Spero Therapeutics Inc

TXTM

Protext Mobility Inc

Market Cap

SPRO$69M

TXTM$65M

Enterprise Value

SPRO$19M

TXTM$66M

Price

SPRO$1.20

TXTM$0.01

P/E Ratio

SPRO9.42x

TXTMN/A

P/S Ratio

SPRO1.48x

TXTM81,318.79x

EV/Sales

SPRO0.40x

TXTM83,093.29x

EV/EBITDA

SPRO0.78x

TXTM0.00x

P/B Ratio

SPRO1.57x

TXTMN/A

P/FCF Ratio

SPRO3.55x

TXTMN/A

EV/FCF

SPRO0.96x

TXTM-94.20x

PEG Ratio

SPRON/A

TXTMN/A

Forward P/E (NTM)

SPRON/A

TXTMN/A

Forward P/S (NTM)

SPRON/A

TXTMN/A

Revenue (TTM)

SPRO$47M

TXTM$800

Revenue Growth (YoY)

SPRO-3.3%

TXTMN/A

Forward Rev Growth

SPRO300.0%

TXTM0.0%

Gross Margin (TTM)

SPRO0.0%

TXTM87.5%

Operating Margin (TTM)

SPRO22.1%

TXTM0.0%

EBITDA Margin (TTM)

SPRO51.2%

TXTM-128712.5%

Net Margin (TTM)

SPRO15.7%

TXTM-276562.5%

FCF Margin (TTM)

SPRO41.7%

TXTM-88212.5%

Net Income (TTM)

SPRO$7M

TXTM$-2M

FCF (TTM)

SPRO$20M

TXTM$-706K

EPS (TTM)

SPRO$0.13

TXTM-$0.01

ROE (TTM)

SPRO16.2%

TXTM-940097.1%

ROA (TTM)

SPRO12.6%

TXTM-522856.0%

ROIC (TTM)

SPRO16.2%

TXTM0.0%

Cash

SPRO$51M

TXTM$700

Debt

SPRO$0

TXTM$1M

Net Cash/Debt

SPRO$51M

TXTM$-1M

Current Ratio (TTM)

SPRO6.12x

TXTM0.00x

Quick Ratio (TTM)

SPRO6.03x

TXTM0.00x

Debt/Equity (TTM)

SPRO0.00x

TXTM0.00x

Debt/Assets (TTM)

SPRO0.0%

TXTM0.0%

Interest Coverage (TTM)

SPRON/A

TXTMN/A

Net Debt/EBITDA (TTM)

SPRO0.00x

TXTM0.00x

Beta

SPRO1.54

TXTM-3.17

52W Performance

SPRO-47.4%

TXTM184.6%

YTD Performance

SPRO-48.9%

TXTM100.0%

% from 52W High

SPRO-61.0%

TXTM-26.0%

% from 52W Low

SPRO11.1%

TXTM393.3%

Asset Turnover (TTM)

SPRO1.00x

TXTM0.04x

FCF Yield (TTM)

SPRO28.2%

TXTM-1.1%

Earnings Yield (TTM)

SPRO10.6%

TXTM-3.4%

Dividend Yield (TTM)

SPRON/A

TXTMN/A

Rule of 40

SPRO38.4

TXTM-88,212.5

EV/GP/RG

SPRON/A

TXTMN/A

Ticker research

View SPRO research View TXTM research

Metric	SPRO Spero Therapeutics Inc	TXTM Protext Mobility Inc
Market & Valuation
Market Cap	$69M	$65M
Enterprise Value	$19M	$66M
Price	$1.20	$0.01
P/E Ratio	9.42x	N/A
P/S Ratio	1.48x	81,318.79x
EV/Sales	0.40x	83,093.29x
EV/EBITDA	0.78x	0.00x
P/B Ratio	1.57x	N/A
P/FCF Ratio	3.55x	N/A
EV/FCF	0.96x	-94.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$47M	$800
Revenue Growth (YoY)	-3.3%	N/A
Forward Rev Growth	300.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	87.5%
Operating Margin (TTM)	22.1%	0.0%
EBITDA Margin (TTM)	51.2%	-128712.5%
Net Margin (TTM)	15.7%	-276562.5%
FCF Margin (TTM)	41.7%	-88212.5%
Net Income (TTM)	$7M	$-2M
FCF (TTM)	$20M	$-706K
EPS (TTM)	$0.13	-$0.01
ROE (TTM)	16.2%	-940097.1%
ROA (TTM)	12.6%	-522856.0%
ROIC (TTM)	16.2%	0.0%
Financial Health
Cash	$51M	$700
Debt	$0	$1M
Net Cash/Debt	$51M	$-1M
Current Ratio (TTM)	6.12x	0.00x
Quick Ratio (TTM)	6.03x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	-3.17
52W Performance	-47.4%	184.6%
YTD Performance	-48.9%	100.0%
% from 52W High	-61.0%	-26.0%
% from 52W Low	11.1%	393.3%
Efficiency & Yields
Asset Turnover (TTM)	1.00x	0.04x
FCF Yield (TTM)	28.2%	-1.1%
Earnings Yield (TTM)	10.6%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	38.4	-88,212.5
EV/GP/RG	N/A	N/A
Ticker research	View SPRO research	View TXTM research